tiprankstipranks
Lakefront Biotherapeutics (LKFT)
NASDAQ:LKFT
US Market
LKFT
Lakefront Biotherapeutics
RESEARCH TOOLSreports
Want to see LKFT full AI Analyst Report?

Lakefront Biotherapeutics (LKFT) Ratios

549 Followers

Lakefront Biotherapeutics Ratios

LKFT's free cash flow for Q1 2026 was €0.26. For the 2026 fiscal year, LKFT's free cash flow was decreased by € and operating cash flow was €-9.83. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 30.48 20.15 9.97 9.02 8.11
Quick Ratio
 30.30 20.00 9.81 8.84 8.01
Cash Ratio
 0.67 0.57 0.19 0.39 0.97
Solvency Ratio
 4.11 2.21 0.10 0.16 -0.07
Operating Cash Flow Ratio
 -3.00 -1.68 -0.96 -0.95 -0.96
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
€ 2.94B€ 2.91B€ 2.10B€ 2.30B€ 2.03B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.04 1.05 1.43 1.56 1.87
Debt Service Coverage Ratio
 0.00 170.31 49.54 25.04 0.36
Interest Coverage Ratio
 0.00 226.16 -206.74 -53.36 -14.32
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.10 0.14 0.19 0.17 0.47
Net Debt to EBITDA
 -0.11 -0.23 -1.21 -3.08 -125.57
Profitability Margins
Gross Profit Margin
98.01%97.33%87.35%100.00%100.00%
EBIT Margin
38.14%27.25%-0.79%3.08%-25.57%
EBITDA Margin
38.14%32.27%15.72%21.29%1.60%
Operating Profit Margin
57.14%45.08%-68.33%-36.82%-54.32%
Pretax Profit Margin
45.14%27.05%-1.12%2.35%-29.37%
Net Profit Margin
46.83%28.85%26.88%88.31%-90.36%
Continuous Operations Profit Margin
46.75%28.72%-0.47%-1.66%-29.60%
Net Income Per EBT
103.73%106.65%-2401.36%3763.50%307.68%
EBT Per EBIT
79.01%60.01%1.64%-6.37%54.06%
Return on Assets (ROA)
14.49%9.42%1.79%4.86%-4.60%
Return on Equity (ROE)
16.28%9.92%2.56%7.57%-8.63%
Return on Capital Employed (ROCE)
17.68%15.41%-4.96%-2.25%-3.11%
Return on Invested Capital (ROIC)
17.67%15.40%-2.06%1.59%-3.11%
Return on Tangible Assets
14.50%9.42%1.90%5.09%-4.82%
Earnings Yield
30.93%20.03%4.22%8.73%-8.01%
Efficiency Ratios
Receivables Turnover
 19.32 20.91 5.81 3.65 3.12
Payables Turnover
 0.22 0.91 0.36 0.00 0.00
Inventory Turnover
 1.18 1.32 0.68 0.00 0.00
Fixed Asset Turnover
 13.56 13.79 2.24 1.90 1.56
Asset Turnover
 0.31 0.33 0.07 0.06 0.05
Working Capital Turnover Ratio
 0.35 0.00 0.09 0.07 0.06
Cash Conversion Cycle
 -1.35K -106.86 -424.89 99.97 117.02
Days of Sales Outstanding
 18.90 17.46 62.87 99.97 117.02
Days of Inventory Outstanding
 310.39 276.09 535.96 0.00 0.00
Days of Payables Outstanding
 1.68K 400.41 1.02K 0.00 0.00
Operating Cycle
 329.28 293.55 598.82 99.97 117.02
Cash Flow Ratios
Operating Cash Flow Per Share
 -4.58 -3.91 -4.84 -6.16 -7.62
Free Cash Flow Per Share
 -4.71 -4.12 -6.08 -6.45 -8.18
CapEx Per Share
 0.13 0.21 1.24 0.29 0.56
Free Cash Flow to Operating Cash Flow
 1.03 1.05 1.26 1.05 1.07
Dividend Paid and CapEx Coverage Ratio
 -34.54 -18.58 -3.90 -21.06 -13.55
Capital Expenditure Coverage Ratio
 -34.54 -18.58 -3.90 -21.06 -13.55
Operating Cash Flow Coverage Ratio
 -46.87 -37.23 -27.30 -42.31 -22.85
Operating Cash Flow to Sales Ratio
 -0.29 -0.23 -1.16 -1.69 -2.07
Free Cash Flow Yield
-19.06%-16.94%-22.89%-17.54%-19.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 3.18 4.99 23.71 11.45 -12.49
Price-to-Sales (P/S) Ratio
 1.49 1.44 6.37 10.11 11.29
Price-to-Book (P/B) Ratio
 0.48 0.50 0.61 0.87 1.08
Price-to-Free Cash Flow (P/FCF) Ratio
 -5.00 -5.90 -4.37 -5.70 -5.07
Price-to-Operating Cash Flow Ratio
 -5.15 -6.22 -5.49 -5.97 -5.44
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.00 -0.01 -0.12 -0.17
Price-to-Fair Value
 0.48 0.50 0.61 0.87 1.08
Enterprise Value Multiple
 3.75 4.24 39.33 44.43 577.68
Enterprise Value
 1.52B 1.52B 1.70B 2.27B 2.24B
EV to EBITDA
 2.84 4.24 39.33 44.43 577.68
EV to Sales
 1.46 1.37 6.18 9.46 9.27
EV to Free Cash Flow
 -5.05 -5.61 -4.24 -5.33 -4.16
EV to Operating Cash Flow
 -5.20 -5.91 -5.32 -5.59 -4.47
Tangible Book Value Per Share
 49.38 49.09 40.25 39.41 35.16
Shareholders’ Equity Per Share
 49.39 49.10 43.80 42.40 38.45
Tax and Other Ratios
Effective Tax Rate
 -0.04 -0.06 0.58 1.71 >-0.01
Revenue Per Share
 15.84 16.88 4.17 3.64 3.67
Net Income Per Share
 7.42 4.87 1.12 3.21 -3.32
Tax Burden
 1.04 1.07 -24.01 37.64 3.08
Interest Burden
 0.88 0.99 1.42 0.76 1.15
Research & Development to Revenue
 0.29 0.41 1.22 1.01 1.12
SG&A to Revenue
 0.13 0.10 0.35 0.39 0.42
Stock-Based Compensation to Revenue
 -0.01 0.02 0.00 0.24 0.37
Income Quality
 -0.60 -0.80 -4.32 -1.92 2.30
Currency in EUR